英文别名 |
N-[1-hydroxy-14-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]tetradec-4-en-2-yl]hexadecanamide;N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-erythro-sphingosine;C-12 NBD Ceramide;C12 NBD Ceramide (d18:1/12:0);C12-NBD-ceramide;C12-NBD-ceramide;N-C12-NBD-D-erythro-Sphingosine;N-C12-NBD-D-erythro-Sphingosine;HY-141575;HY-141575;N-[12-[(7-Nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-ceramide;N-[12-[(7-Nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-ceramide;C12-NBD Ceramide;C12-NBD Ceramide;CHEBI:143826;CHEBI:143826;DA-75906;DA-75906;J-013179;J-013179;CS-0181668;CS-0181668;Dodecanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-12-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-;Dodecanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-12-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-;CHEMBL2146975;CHEMBL2146975;202850-01-9;202850-01-9;N-(NBD-Aminolauroyl)ceramide, >=98%;N-(NBD-Aminolauroyl)ceramide, >=98%;N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]-12-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]dodecanamide;N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]-12-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]dodecanamide |